You appear to be using incognito/private browsing mode or an ad blocker, which may adversely affect your experience on the site. Please disable any ad blockers and view the site in non-private mode.
For in vitro diagnostic use. Others B2MG IVD B2MG CPS_000044 Tina-quant β2-Microglobulin 08 047 499 190 8 047 499 190 08047499190 8047499190 08047499190 B2MG, 140T, cobas c 701/702 B2MG 07613336120002 Reagents, kits 140 tests cobas c 701/702 true 08 047 430 190 8 047 430 190 08047430190 8047430190 08047430190 B2MG, 140T, cobas c 311, cobas c 501/502 B2MG 07613336119990 Reagents, kits 140 tests cobas c 311/501/502 true 08 105 529 190 8 105 529 190 08105529190 8105529190 08105529190 B2MG, 150T, cobas c pack green B2MG 07613336133583 Reagents, kits 150 tests cobas c 303/503/703 true 05 950 783 190 5 950 783 190 05950783190 5950783190 05950783190 B2MG 140Tests cobas c 701 B2MG 04015630928781 Reagents, kits 140 tests cobas c 701/702 true 0208047499190c701u B2MG Tina-quant β2-Microglobulin (urine application) en 5 FF00000006B2A10E FF000000060A8F0E 08047499190 2492 cobas c 702 310 cobas c 701 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoturbidimetric assay for the quantitative in vitro determination of β2‑microglobulin (B2MG) in human urine on cobas c systems. en 0208047499190c701 B2MG Tina-quant β2-Microglobulin (serum/plasma application) en 3 FF00000006C77F0E FF0000000348A70E 08047499190 2492 cobas c 702 310 cobas c 701 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoturbidimetric assay for the quantitative in vitro determination of β2‑microglobulin (B2MG) in human serum and plasma on cobas c systems. en 0108047499190c701u B2MG Tina-quant β2-Microglobulin (urine application) en 4 FF000000059EEF0E FF000000032A6D0E 08047499190 2492 cobas c 702 310 cobas c 701 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended use Immunoturbidimetric assay for the quantitative in vitro determination of β2‑microglobulin (B2MG) in human urine on cobas c systems. en 08047499500 B2MG Tina-quant β2-Microglobulin en 6 FF00000006F6C40E FF000000032A660E 08047499190 2492 cobas c 702 310 cobas c 701 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoturbidimetric assay for the quantitative in vitro determination of β2‑microglobulin (B2MG) in human serum, plasma and urine on cobas c systems. en 08047430500 B2MG Tina-quant β2-Microglobulin en 5 FF000000069E390E FF000000030C2D0E 08047430190 308 cobas c 311 2324 cobas c 502 309 cobas c 501 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoturbidimetric assay for the quantitative in vitro determination of β2‑microglobulin (B2MG) in human serum, plasma and urine on cobas c systems. en 0108047430190c501u B2MG Tina-quant β2-Microglobulin (urine application) en 4 FF000000059C830E FF000000032A5B0E 08047430190 308 cobas c 311 2324 cobas c 502 309 cobas c 501 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended use Immunoturbidimetric assay for the quantitative in vitro determination of β2‑microglobulin (B2MG) in human urine on cobas c systems. en 0108105529190uc503 B2MG Tina-quant β2-Microglobulin (urine application) en 5 FF00000005A0110E FF00000004C1F30E 08105529190 9493 cobas c 303 8481 cobas c 503 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended use Immunoturbidimetric assay for the quantitative in vitro determination of β2‑microglobulin (B2MG) in human urine on cobas c systems. en 0208105529190c503 B2MG Tina-quant β2-Microglobulin (serum/plasma application) en 4 FF000000069E5A0E FF00000003E4F60E 08105529190 9493 cobas c 303 8481 cobas c 503 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoturbidimetric assay for the quantitative in vitro determination of β2‑microglobulin (B2MG) in human serum and plasma on cobas c systems. en 08105529500 B2MG Tina-quant β2-Microglobulin en 7 FF00000006E9AF0E FF00000006E9AF0E 08105529190 10299 cobas c 703 9493 cobas c 303 8481 cobas c 503 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoturbidimetric assay for the quantitative in vitro determination of β2‑microglobulin (B2MG) in human serum, plasma and urine on cobas c systems. en 08105529500 B2MG Tina-quant β2-Microglobulin en 6 FF000000069E1A0E FF00000004C1D10E 08105529190 9493 cobas c 303 8481 cobas c 503 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoturbidimetric assay for the quantitative in vitro determination of β2‑microglobulin (B2MG) in human serum, plasma and urine on cobas c systems. en 0208105529190c503u B2MG Tina-quant β2-Microglobulin (urine application) en 4 FF000000069E5B0E FF00000005BA570E 08105529190 9493 cobas c 303 8481 cobas c 503 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoturbidimetric assay for the quantitative in vitro determination of β2‑microglobulin (B2MG) in human urine on cobas c systems. en 0005950783190c701 B2MG Tina-quant β2-Microglobulin en 8 FF000000047FD80E FF00000000136B0E 05950783190 2492 cobas c 702 310 cobas c 701 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended use Immunoturbidimetric assay for the quantitative in vitro determination of β2‑microglobulin in human serum and plasma on Roche/Hitachi cobas c systems. en